Quoin Pharmaceuticals Ltd (QNRX) Directors and Executive Officers

Officers & Directors

Dr. Michael Myers
Chairman and Chief Executive Officer

Michael Sember
Director

Denise Carter
Director and Chief Operating Officer

James Culverwell
Director

Dennis Langer
Director

Natalie Leong
Director

Joseph Cooper
Director

Gordon Dunn
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Marcum LLP
Auditor since the company s establishment ,

Quoin Pharmaceuticals Ltd currently has 6 employees.

News about Quoin Pharmaceuticals Ltd Key Personnel

Quoin Pharmaceuticals' Public Offering Raises Concerns as Company Records Negative ROI and Trails Behind Industry Peers in Financial Performance.

Quoin Pharmaceuticals Public Offering Raises Concerns about Company s Financial Health
ASHBURN, Va., March 05, 2024 - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) announced the pricing of its public offering, raising approximately $6.5 million in gross proceeds. However, the financial performance of the specialty pharmaceutical company raises concerns about its long-term viability.
Quoin Pharmaceuticals, focused on rare and orphan diseases, faces significant challenges as it recorded a cumulative net loss of $-16 million in the 12 months ending in the third quarter of 2023. This resulted in a negative return on investment (ROI) of -134.02%, which is alarming. Furthermore, within the healthcare sector...